ARQT
Arcutis Biotherapeutics, Inc. - Common stock NASDAQ
- Avg call return
- +3.1%
- +1.5% vs. index
- Scored calls
- 1
- Channels
- 1
- Win Rate
- 100%
- Side taken
- 1Buy 0Sell
1 scored calls · 1 channels · first tracked 01 Sep 2026
ARQT: tracked call record. Across the full tracked record, 1 of 1 published calls are scored, with an average call return of 3.12%. Scored calls were published from 01 Sep 2026 to 01 Sep 2026, measured from each entry price to its latest available close (price dates: 08 Oct 2026 to 08 Oct 2026). Average benchmark excess is 1.52 percentage points, based on 1 of the 1 scored calls only. Unscored calls are excluded from averages. Holding periods and price freshness vary. These are averages of directional call returns, not an investable portfolio return; fees, dividends and execution costs are not included.
Who is calling ARQT
Last 12 months · 1 buying · 0 selling
-
01
WallStreetZen Buy Calls 1 Return +3.1% Show calls
-
01 Sep 2026
Buy
Entry
$23.75
Now
$24.49
+3.1%
vs. index
+1.5%
AI-extracted call. Cite this call
Wall Street is leaning into these shares with all six covering analysts in the buy or strong buy category.
-
01 Sep 2026
Buy
Entry
$23.75
Now
$24.49
+3.1%
vs. index
+1.5%
Every video calling ARQT
Understand these figures or report an error: Methodology Corrections policy